Diagnostic Discovery Research
Specificity that scales
Customizable antibody discovery workflows engineered for high-affinity binding, sensitivity, and exquisite specificity to address demanding diagnostic challenges.
Every diagnostic matters. Every result counts.
In diagnostics, accuracy matters. MindWalk unites advanced lab rigor with scalable development to deliver antibodies with specificity, sensitivity, and reproducibility. With a validated discovery platform and rapid screening formats, our diagnostic antibody discovery workflow supports researchers as projects move from discovery toward downstream development.
500+ antibody diagnostic programs
Your extended team
Customized strategies for diagnostic antibody discovery. Decades of client retention built on scientific rigor and trusted collaboration.
>98% discovery success rate
with leading B cell technology*
* “Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.
Diagnostic performance
From standard to complex programs, our antibodies are characterized by sensitivity, specificity, and cross-platform accuracy.
Specificity
Target the most difficult-to-distinguish markers
Sensitivity
Designed for hard-to-find, low-abundance targets with precision
Reproducibility
Consistent performance across assays with low batch-to-batch variation
Stability
Durability and performance that withstand demanding workflows
Comprehensive expertise for advanced diagnostic solutions
Advanced diagnostic lab research:
Our antibody discovery platforms span the full journey—from target identification through protein production, with antibodies characterized by precise specificity, low background, and high sensitivity.
Integrated LensAI™ support:
Customized intelligence built for you, ready when you need it, revealing insights that help shape more refined clones.
Flexible protein production:
High-throughput, consistent expression that scales as programs progress.
Where our research makes a broad impact
Oncology + Infectious Disease + Neurodegeneration + Metabolic Disease + Rare Disease + Inflammation + Market Kits
Diagnostics discovery across complex targets
Antibody discovery + development
Wide-range of flexible applications
Target
- Target Analysis: Experience-based Antigen Design
- Tool Generation: Custom Antigen Production, Assay Development
Discovery
- Immunization: Standard, Rapid, Custom
- Hit Generation & Candidate Selection: B cell Discovery, Hybridoma Discovery
Lead
- Lead Characterization: Target Interaction Analysis
- LensAI HYFT Prime™: Binding Affinity Optimization, Target Specificity and Selectivity
- Target- and Application-specific Screening
- Protein Production: Recombinant Protein Expression in CHO, HEK293, E.coli
Stable Production Cell Line
Secure Cryostorage
Functional Selection
- Epitope Mapping
- Affinity
- Specificity
- Competing/Non-competing
- Pairing Identification
- Application Relevant Screening
Species Diversity
+ Rabbit
+ Rodent
Advanced Technology
+ B cell Select®
+ Hybridoma
Format Options
- Full-length IgG
- Custom Formats
Used by teams across 19 of the top 20 global pharma companies, next-generation biotechs, and leading research institutions
Stronger starts.
#1 ranking lab1
1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118
Protein production
Leading diagnostics developers rely on our high-purity, reproducible proteins in long-standing relationships.
Start your diagnostic program today
Connect with scientists who understand diagnostics from discovery through development
Four ways to access MindWalk
We build it
Customizable offerings in biologics discovery—from target analysis to optimized leads.
You build it
Access to state-of-the-art LensAI SaaS Platform.
The Vault
Smarter starts: a portfolio of partner-ready assets.
Partnership
We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.